Pongamia Glabra Seed Oil

Pongamia Glabra Seed Oil and pregnancy

Caution Advised

• Absorbed into the body

Pongamia Glabra Seed Oil, also known as karanja oil, is extracted from the pongamia tree and contains flavonoids, fatty acids, and bioactive compounds. While it has antimicrobial and anti-inflammatory properties, it is traditionally used in agricultural pest control and medicinal applications. Specific data on the safety of topical karanja oil during pregnancy is limited. The oil contains bioactive compounds that have demonstrated systemic effects in traditional medicine, and as a fat-soluble oil, it may have greater skin penetration than aqueous ingredients. While no direct teratogenic effects have been documented, the lack of safety studies during pregnancy and the oil's potent bioactive profile warrant caution. Traditional medicine sources suggest avoiding internal use during pregnancy, though topical application is less studied. No major regulatory body has issued specific guidance on karanja oil use during pregnancy. However, many obstetricians and dermatologists recommend a conservative approach with lesser-known botanical oils that have limited safety data during pregnancy, particularly those with known pharmacological activities. Women who are pregnant may prefer to choose oils with more established safety profiles.

Pongamia Glabra Seed Oil and breastfeeding

Safe to Use

Pongamia Glabra Seed Oil is a botanical oil used topically in cosmetics. When applied to skin away from the breast area, it is unlikely to transfer to breast milk in significant amounts. There are no specific studies on karanja oil use during breastfeeding. However, topical application of botanical oils generally poses minimal risk to breastfed infants when not applied directly to the breast or nipple area. The bioactive compounds in karanja oil could theoretically be absorbed through skin, but the amounts would be minimal with typical cosmetic use. Lactation consultants generally advise caution with potent botanical ingredients near the breast area but do not restrict topical use elsewhere. If using products containing this oil, avoid application to the chest area and ensure thorough hand washing before handling your baby.

Pongamia Glabra Seed Oil and postpartum

Safe to Use

• Irritant

Pongamia Glabra Seed Oil may offer anti-inflammatory benefits for postpartum skin concerns, though its potency means it could cause irritation in some individuals. Postpartum women not breastfeeding can use this ingredient with normal precautions for any botanical oil. The main consideration is potential for skin irritation or allergic reaction. Patch testing is recommended before widespread use, particularly for those with sensitive or compromised skin barriers common in the postpartum period.

Pongamia Glabra Seed Oil and trying to conceive

Safe to Use

Pongamia Glabra Seed Oil has limited data regarding its effects on fertility. However, topical cosmetic use is unlikely to impact conception efforts. The traditional medicinal use of karanja oil does not indicate hormone-disrupting properties at topical cosmetic concentrations. Women trying to conceive can generally use products containing this oil, though those preferring maximum caution may opt for botanical oils with more extensive safety documentation.

Pongamia Glabra Seed Oil and PCOS

Safe to Use

Pongamia Glabra Seed Oil has anti-inflammatory and antimicrobial properties that may benefit PCOS-related skin concerns such as acne. There is no evidence of hormonal activity or androgen-mimetic effects. The oil's antimicrobial properties could be beneficial for managing inflammatory acne often associated with PCOS. However, its moderate comedogenic rating means it may not be suitable for all PCOS patients, particularly those prone to cystic acne. Dermatologists do not restrict karanja oil for PCOS patients, though individual skin reactions vary. Women with PCOS who have very oily or acne-prone skin may want to patch test or choose lighter oils.

Pongamia Glabra Seed Oil and general use

Safe to Use

• Common allergen
• Irritant

Pongamia Glabra Seed Oil is a botanical oil with antimicrobial, anti-inflammatory, and insecticidal properties. It is more commonly used in traditional medicine and agricultural applications than in mainstream cosmetics. The oil can cause skin irritation or allergic reactions in sensitive individuals. Its bioactive compounds, while potentially beneficial, also mean it has higher potency than many cosmetic oils. Patch testing is recommended, particularly for those with sensitive skin or known allergies to botanical ingredients. Some individuals may experience contact dermatitis. This ingredient is not specifically regulated or restricted by the FDA or EU Cosmetics Regulation. However, its use in cosmetics is less common than other botanical oils, and long-term safety data in cosmetic applications is limited.

Everything else flagged for the same profiles

• Flagged in pregnancy

Related ingredients

Ingredients suggested in place of Pongamia Glabra Seed Oil, each one with its own page here.

• Squalane

Ingredients that raise the same concerns.

• Parfum/FragranceIrritant, Common allergen, Absorbed into the body
• Lavandula Angustifolia OilIrritant, Common allergen, Absorbed into the body
• Melaleuca Alternifolia Leaf OilIrritant, Common allergen, Absorbed into the body
• EugenolIrritant, Common allergen, Absorbed into the body
• Rosmarinus Officinalis Leaf OilIrritant, Common allergen, Absorbed into the body
• DMDM HydantoinIrritant, Common allergen, Absorbed into the body

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on 15 September 2026.